Company
Headquarters: Zhubei, Taiwan
TW$1.03 Billion
TWD as of Jan. 1, 2024
US$33.7 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Wiltrom Co., Ltd. researches, develops, and produces a range of implantable medical devices. Its products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. The company is based in Zhubei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Wiltrom Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6767 wb_incandescent